Exon 3-deleted/full-length growth hormone receptor polymorphism genotype frequencies in Spanish short small-for-gestational-age (SGA) children and adolescents (n=247) and in an adult control population (n=289) show increased fl/fl in short SGA

被引:61
作者
Audi, Laura
Esteban, Cristina
Carrascosa, Antonio
Espadero, Rosa
Perez-Arroyo, Annalisa
Arjona, Rosa
Clemente, Maria
Wollmann, Hartmut
Fryklund, Linda
Parodi, Luis A.
机构
[1] Hosp Valle De Hebron, Unidad Invest Endocrinol Pediat, Barcelona 08035, Spain
[2] Autonomous Univ Barcelona, Hosp Vall Hebron, Dept Pediat, Barcelona 08035, Spain
[3] Pfizer Spain, Med Unit, Madrid 28108, Spain
[4] Pfizer GmbH, WW Md Endocrine Care, D-76032 Karlsruhe, Germany
[5] Pfizer Inc, New York, NY 10017 USA
关键词
D O I
10.1210/jc.2006-0828
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Context: A polymorphism in the human GH receptor gene (d3/fl-GHR) resulting in genomic deletion of exon 3 has been associated with the degree of height increase in response to GH therapy. Objective: The objective of the study was to evaluate the frequencies of d3/fl-GHR polymorphism genotypes in control and short small-for-gestational-age (SGA) populations. Design: An adult control population with heights normally distributed (ACPNH) between -2 and +2 SD score (SDS) and a short nonGH-deficient SGA child population were selected. Setting: Thirty Spanish hospitals participated in the selection of the short non-GH-deficient SGA children in the setting of a controlled, randomized trial, and one of these hospitals selected the ACPNH. Controls and Patients: Two hundred eighty-nine adult subjects of both sexes constituted the ACPNH and 247 children and adolescents of both sexes the short SGA patients. Main Outcome Measures: Heights and weights were recorded in the ACPNH, and auxologic and biochemical data were recorded at each hospital for the SGA patients; d3/fl-GHR genotypes were determined and data analyzed in a single hospital. Results: In short SGA patients, d3/fl-GHR genotype frequencies were significantly different from those in ACPNH, with a higher frequency of fl/fl genotype (P < 0.0001). In ACPNH, a trend toward diminished d3/d3 genotype frequency was observed in the shortest height group (Height <= -1 SDS and >= -2 SDS, n = 60). Conclusions: Our data showed significant differences in the frequency distribution of the d3/fl-GHR genotypes between a normally distributed adult height population and short SGA children, with the biologically less active fl/fl genotype being almost twice as frequent in SGA patients. These data suggest that the d3/fl-GHR polymorphism might be considered among the factors that contribute to the phenotypic expression of growth.
引用
收藏
页码:5038 / 5043
页数:6
相关论文
共 24 条
[11]  
Hernandez M, 2000, TRATADO ENDOCRINOLOG, P1441
[12]   Genetic variation at the growth hormone (GH1) and growth hormone receptor (GHR) loci as a risk factor for hypertension and stroke [J].
Horan, M ;
Newsway, V ;
Lewis, YMD ;
Easter, TE ;
Rees, DA ;
Mahto, A ;
Millar, DS ;
Procter, AM ;
Scanlon, MF ;
Wilkinson, IB ;
Hall, IP ;
Wheatley, A ;
Blakey, J ;
Bath, PMW ;
Cockcroft, JR ;
Krawczak, M ;
Cooper, DN .
HUMAN GENETICS, 2006, 119 (05) :527-540
[13]   Growth hormone (GH) pharmacogenetics: Influence of GH receptor exon 3 retention or deletion on first-year growth response and final height in patients with severe GH deficiency [J].
Jorge, AAL ;
Marchisotti, FG ;
Montenegro, LR ;
Carvalho, LR ;
Mendonca, BB ;
Arnhold, IJP .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2006, 91 (03) :1076-1080
[14]  
MANTEL J, 2000, J BIOL CHEM, V275, P18664
[15]   The effects of human population structure on large genetic association studies [J].
Marchini, J ;
Cardon, LR ;
Phillips, MS ;
Donnelly, P .
NATURE GENETICS, 2004, 36 (05) :512-517
[16]   Common polymorphisms of the growth hormone (GH) receptor do not correlate with the growth response to exogenous recombinant human GH in GH-deficient children [J].
Pilotta, A ;
Mella, P ;
Filisetti, M ;
Felappi, B ;
Prandi, E ;
Parrinello, G ;
Notarangelo, LD ;
Buzi, F .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2006, 91 (03) :1178-1180
[17]   New molecular mechanisms of GH resistance [J].
Rosenfeld, RG ;
Hwa, V .
EUROPEAN JOURNAL OF ENDOCRINOLOGY, 2004, 151 :S11-S15
[18]   Growth hormone receptor mutations in children idiopathic short stature [J].
Sanchez, JE ;
Perera, E ;
Baumbach, L ;
Cleveland, WW .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1998, 83 (11) :4079-4083
[19]   EXPRESSION AND BINDING-PROPERTIES OF 2 ISOFORMS OF THE HUMAN GROWTH-HORMONE RECEPTOR [J].
SOBRIER, ML ;
DUQUESNOY, P ;
DURIEZ, B ;
AMSELEM, S ;
GOOSSENS, M .
FEBS LETTERS, 1993, 319 (1-2) :16-20
[20]   Alternative splicing of exon 3 of the human growth hormone receptor is the result of an unusual genetic polymorphism [J].
StallingsMann, ML ;
Ludwiczak, RL ;
Klinger, KW ;
Rottman, F .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1996, 93 (22) :12394-12399